HYF

Immunoprecise Antibodies

HYFT

Immunoprecise Antibodies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer Lynne Bath, with a market cap of $71.5M.

Market cap

$71.47M+114%

We’re still putting together Immunoprecise Antibodies’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Earnings

Q1 2026 report

March 12, 2026

Revenue$3.1MMiss by $330.2K EPS-$0.06Miss by $0.02

Read the full report

Next report

Jul 23, 2026 (in a month)

Revenue estimate$3.2M

EPS estimate-$0.05

Profile

CountryCanada

Listed2010

Employees102.0

CEOJennifer Lynne Bath

SectorHealthcare

IndustryBiotechnology

Websiteipatherapeutics.com

FilingsSEC EDGAR